Sophia S. Chen

Array ( [id] => 9983136 [patent_doc_number] => 09028840 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-12 [patent_title] => 'Ex vivo method for producing a preparation containing CD4+ T cells specific for EBV structural antigens' [patent_app_type] => utility [patent_app_number] => 12/744474 [patent_app_country] => US [patent_app_date] => 2008-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10008 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12744474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6583714 [patent_doc_number] => 20100047764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'Novel surface protein (HBsAg) variant of the hepatitis B virus' [patent_app_type] => utility [patent_app_number] => 12/292747 [patent_app_country] => US [patent_app_date] => 2008-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13053 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047764.pdf [firstpage_image] =>[orig_patent_app_number] => 12292747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6434264 [patent_doc_number] => 20100278858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'PROCESS FOR PREPARING ATTENUATED VIRAL STRAINS' [patent_app_type] => utility [patent_app_number] => 12/743952 [patent_app_country] => US [patent_app_date] => 2008-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9235 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0278/20100278858.pdf [firstpage_image] =>[orig_patent_app_number] => 12743952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5379716 [patent_doc_number] => 20090191555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'HCV NS3-NS4 Protease Resistance Mutants' [patent_app_type] => utility [patent_app_number] => 12/272425 [patent_app_country] => US [patent_app_date] => 2008-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 27224 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191555.pdf [firstpage_image] =>[orig_patent_app_number] => 12272425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10114652 [patent_doc_number] => 09149517 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-06 [patent_title] => 'Multitype HPV peptide compositions and methods for treatment or prevention of human papillomavirus infection' [patent_app_type] => utility [patent_app_number] => 12/740815 [patent_app_country] => US [patent_app_date] => 2008-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 25238 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12740815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5330613 [patent_doc_number] => 20090111090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'METHOD FOR DETECTING INTEGRATED HPV DNA' [patent_app_type] => utility [patent_app_number] => 12/262508 [patent_app_country] => US [patent_app_date] => 2008-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9190 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20090111090.pdf [firstpage_image] =>[orig_patent_app_number] => 12262508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6622094 [patent_doc_number] => 20100311038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'NEAR FULL-GENOME ASSAY OF HCV DRUG RESISTANCE' [patent_app_type] => utility [patent_app_number] => 12/739648 [patent_app_country] => US [patent_app_date] => 2008-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9670 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311038.pdf [firstpage_image] =>[orig_patent_app_number] => 12739648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6441281 [patent_doc_number] => 20100104555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'HCV neutralizing epitopes' [patent_app_type] => utility [patent_app_number] => 12/290017 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 34671 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20100104555.pdf [firstpage_image] =>[orig_patent_app_number] => 12290017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5264427 [patent_doc_number] => 20090117112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'IMMUNOMODULATORY COMPOSITIONS AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 12/246291 [patent_app_country] => US [patent_app_date] => 2008-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 61782 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20090117112.pdf [firstpage_image] =>[orig_patent_app_number] => 12246291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5277980 [patent_doc_number] => 20090130112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'SPATIAL FOR ALTERING CELL PROLIFERATION' [patent_app_type] => utility [patent_app_number] => 12/239466 [patent_app_country] => US [patent_app_date] => 2008-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 39364 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130112.pdf [firstpage_image] =>[orig_patent_app_number] => 12239466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8305675 [patent_doc_number] => 08227211 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-24 [patent_title] => 'Humanized anti-CCR2 antibodies and methods of use therefor' [patent_app_type] => utility [patent_app_number] => 12/235765 [patent_app_country] => US [patent_app_date] => 2008-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 65 [patent_no_of_words] => 35180 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12235765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5271038 [patent_doc_number] => 20090074814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'DNA Vaccines Encoding Antigen Linked to a Domain That Binds CD40' [patent_app_type] => utility [patent_app_number] => 12/233750 [patent_app_country] => US [patent_app_date] => 2008-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6998 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074814.pdf [firstpage_image] =>[orig_patent_app_number] => 12233750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5284477 [patent_doc_number] => 20090098152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'Vaccines Containing Canine Parvovirus Genetic Variants' [patent_app_type] => utility [patent_app_number] => 12/211174 [patent_app_country] => US [patent_app_date] => 2008-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10283 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20090098152.pdf [firstpage_image] =>[orig_patent_app_number] => 12211174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5943571 [patent_doc_number] => 20110104191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'MALVA MOSAIC VIRUS AND VIRUS-LIKE PARTICLES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/677772 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 32164 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104191.pdf [firstpage_image] =>[orig_patent_app_number] => 12677772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5322924 [patent_doc_number] => 20090060914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'DEIMMUNIZED MONOCLONAL ANTIBODIES FOR PROTECTION AGAINST HIV EXPOSURE AND TREATMENT OF HIV INFECTION' [patent_app_type] => utility [patent_app_number] => 12/207034 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 14843 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20090060914.pdf [firstpage_image] =>[orig_patent_app_number] => 12207034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5440996 [patent_doc_number] => 20090092635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'HETEROLOGOUS PRIME-BOOST IMMUNIZATION REGIMEN' [patent_app_type] => utility [patent_app_number] => 12/192257 [patent_app_country] => US [patent_app_date] => 2008-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 19115 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20090092635.pdf [firstpage_image] =>[orig_patent_app_number] => 12192257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5310799 [patent_doc_number] => 20090018080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 CYSTEINE MUTANTS' [patent_app_type] => utility [patent_app_number] => 12/185694 [patent_app_country] => US [patent_app_date] => 2008-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39372 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20090018080.pdf [firstpage_image] =>[orig_patent_app_number] => 12185694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5330222 [patent_doc_number] => 20090110699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'Antigen-Adjuvant Compositions and Methods' [patent_app_type] => utility [patent_app_number] => 12/179861 [patent_app_country] => US [patent_app_date] => 2008-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11603 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20090110699.pdf [firstpage_image] =>[orig_patent_app_number] => 12179861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9344796 [patent_doc_number] => 08663943 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-04 [patent_title] => 'Antibodies for discrimination of prions' [patent_app_type] => utility [patent_app_number] => 12/172787 [patent_app_country] => US [patent_app_date] => 2008-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11466 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12172787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5508028 [patent_doc_number] => 20090081235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'PSEUDOMONAS EXOTOXIN A-LIKE CHIMERIC IMMUNOGENS FOR ELICITING A SECRETORY IGA-MEDIATED IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 12/169438 [patent_app_country] => US [patent_app_date] => 2008-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 25171 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081235.pdf [firstpage_image] =>[orig_patent_app_number] => 12169438 [rel_patent_id] =>[rel_patent_doc_number] =>)